chr6-153026512-T-C
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_012419.5(RGS17):c.151A>G(p.Asn51Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000124 in 1,613,428 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_012419.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RGS17 | NM_012419.5 | c.151A>G | p.Asn51Asp | missense_variant | Exon 3 of 5 | ENST00000206262.2 | NP_036551.3 | |
RGS17 | XM_047418634.1 | c.196A>G | p.Asn66Asp | missense_variant | Exon 3 of 5 | XP_047274590.1 | ||
RGS17 | XM_047418635.1 | c.184A>G | p.Asn62Asp | missense_variant | Exon 3 of 5 | XP_047274591.1 | ||
RGS17 | XM_047418636.1 | c.151A>G | p.Asn51Asp | missense_variant | Exon 3 of 5 | XP_047274592.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152182Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000717 AC: 18AN: 251056 AF XY: 0.0000737 show subpopulations
GnomAD4 exome AF: 0.0000109 AC: 16AN: 1461246Hom.: 0 Cov.: 29 AF XY: 0.0000124 AC XY: 9AN XY: 726946 show subpopulations
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152182Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74346 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.151A>G (p.N51D) alteration is located in exon 3 (coding exon 2) of the RGS17 gene. This alteration results from a A to G substitution at nucleotide position 151, causing the asparagine (N) at amino acid position 51 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at